For these studies, pooled MDs were calculated for PAPP-A MoM levels reported for those diagnosed with GDM early in pregnancy and the PAPP-A MoM measurements for those diagnosed with GDM later in pregnancy were pooled with all other studies for each biomarker. This evidence concerns the gene PAPPA and gestational diabetes.